Mylynda Massart, MD, PhD

To close this series, experts explore the challenges and guideline gaps in multi-cancer early detection while considering its potential impact on patient care, accessibility, and improved outcomes.

Experts explore strategies for efficient patient care coordination through early cancer detection, highlighting cost challenges while ensuring timely diagnoses and treatments.

Mylynda Massart, MD, PhD, nuances of blood-based screening (BBS) in early cancer detection and how doctors can respond to various results.

Experts delve into the complexities of cancer screening, from identifying high-risk individuals to counseling patients about the nuances of screening tests, all while aiming for early detection and improved outcomes.

Experts discuss the transition from evidence-based medicine to precision medicine in the context of cancer screening, emphasizing the urgency of implementing multi-cancer screening for broad positive outcomes.

Experts discuss the evolving landscape of multicancer early detection tests, including those in development and currently available.

Experts discuss the emerging landscape of multicancer early detection testing through liquid biopsy, highlighting its potential to revolutionize cancer screening.

Candace Westgate, DO, MPH, FACOG, and Mylynda Massart, MD, PhD, introduce this series on early cancer detection, multi-cancer detection tests, and the role of primary care physicians (PCPs) in preventative care.

Candace Westgate, DO, MPH, FACOG, and Mylynda Massart, MD, PhD, introduce this series on early cancer detection, multi-cancer detection tests, and the role of primary care physicians (PCPs) in preventative care.